Skip to content
Back to results

Fruit and vegetable intake

Eating more fruit and vegetables as part of the everyday diet, rather than counting any single nutrient or aiming at one specific type of produce.

At a glance

  • Evidence: Higher fruit and vegetable intake is associated with lower mortality in cohorts.All-cause mortality · Moderate certainty · Observational association
  • What’s uncertain: A broccoli-preparation biomarker change does not establish disease prevention.
  • First step: Include whole fruit and vegetables across your usual meals.
  • Before you try it: Keep vitamin K intake steady if you take warfarin and follow any prescribed dietary restrictions. All precautions
Read the full takeaway

Mortality associations

Higher fruit and vegetable intake is consistently associated with lower all-cause and cardiovascular mortality in large prospective cohorts, with risk reduction flattening out at roughly five servings a day. Treat that as a well-replicated association, not a proven causal effect size: every supporting study is observational, intakes are self-reported, and residual confounding by income, overall diet quality and health-seeking behaviour is difficult to rule out, which is why the pooled estimates are small and should not be read as the change an individual would achieve.

Cancer evidence

The cancer evidence is genuinely discordant, and this matters more than the headline mortality figures. Observational syntheses show only weak inverse associations for total cancer, close to the null, while randomized trials that substantially increased fruit and vegetable intake found no reduction in cancer incidence or cancer death, and pooled analyses for overall breast cancer found no association. Where cohort associations and randomized trials disagree, the trials are the better guide to whether the practice itself changes the outcome.

Overall interpretation

What the evidence therefore supports is a low-cost, low-risk dietary change with a probable modest long-term benefit, and it does not support any specific claim that eating more produce prevents cancer.

NutritionLong-term healthVaries · Easy · Low
Reviewed Oct 3, 2026
Save

Scientific evidence

What the research shows

Outcome assessments based on research, including its uncertainties and limitations.

All-cause mortality

Finding: Benefit supportedCertainty: Moderatestudies found a benefit from doing this

Evidence basis: observational studies (association, not proof of cause)

Multiple large prospective cohorts and dose-response meta-analyses consistently show a modest inverse association between higher fruit and vegetable intake and all-cause mortality, plateauing near five servings a day.

Population: Adults in prospective cohort studies from North America, Europe and Asia, including 833,234 participants in one synthesis and 1,892,885 participants in another.

Research details

Summary

Multiple large prospective cohorts and dose-response meta-analyses consistently show a modest inverse association between higher fruit and vegetable intake and all-cause mortality, with risk reduction plateauing at roughly five servings (about 400 g) per day. In a meta-analysis of 26 cohorts plus two US cohorts, five servings per day versus two was associated with a summary risk ratio for mortality of 0.87. Because the evidence is observational, residual confounding by socioeconomic position, overall diet quality and health-seeking behaviour cannot be excluded, so the association should not be read as a proven causal effect size.

Why this certainty

Rated Moderate rather than Strong: the association is large in aggregate sample size, consistent in direction across independent syntheses and shows a coherent dose-response shape, but it rests entirely on observational data with known susceptibility to confounding, and no randomised trial has tested fruit and vegetable intake against all-cause mortality as a primary outcome.

Limitations

All estimates come from observational cohorts with self-reported dietary assessment, so residual and unmeasured confounding is likely and reverse causation is possible. Dose-response relations are non-linear and plateau, and the apparent threshold differs between syntheses. Heterogeneity was substantial for all-cause mortality in the largest analysis (I2 = 83%).

Effect estimate

Summary risk ratio for mortality at 5 servings/day of fruit and vegetables = 0.87 (95% CI, 0.85-0.88) (Wang 2021 dose-response meta-analysis). Pooled hazard ratio for all-cause mortality per 1 serving/day increment = 0.95 (95% CI 0.92 to 0.98) (Wang 2014). Summary RR per 200 g/day = 0.90 (95% CI 0.87-0.93, I2 = 83%, n = 15) (Aune 2017).

Cardiovascular disease mortality and events

Finding: Benefit supportedCertainty: Moderatestudies found a benefit from doing this

Evidence basis: observational studies (association, not proof of cause)

Prospective cohorts consistently associate higher fruit and vegetable intake with lower cardiovascular mortality and lower cardiovascular disease incidence, including coronary heart disease and stroke.

Population: Adults without cardiovascular disease at baseline in prospective cohort studies; one synthesis included 1,498,909 participants with 44,013 CVD events and a median 10.5-year follow-up.

Research details

Summary

Prospective cohorts consistently associate higher fruit and vegetable intake with lower cardiovascular mortality and lower cardiovascular disease incidence, including coronary heart disease and stroke. Pooled hazard ratios for cardiovascular mortality are around 0.96 per additional daily serving and summary relative risks around 0.92 per 200 g/day. As with all-cause mortality the evidence is observational and effect sizes are small, so confounding probably accounts for part of the association.

Why this certainty

Rated Moderate: direction and statistical significance are consistent across several independent meta-analyses of large cohorts, but the estimates are small in magnitude, entirely observational, and heterogeneous across endpoints and exposure contrasts. No adequately powered randomised trial has isolated fruit and vegetable intake for cardiovascular event prevention.

Limitations

Observational design throughout, with self-reported intake and likely residual confounding. Pooled relative risks differ appreciably between syntheses (0.92 per 200 g/day versus 0.83 for highest versus lowest intake), which reflects differences in exposure contrasts and analysis methods. Heterogeneity was high for stroke (I2 = 73%) in the largest dose-response analysis.

Effect estimate

Cardiovascular mortality HR per 1 serving/day of fruit and vegetables = 0.96 (95% CI 0.92 to 0.99) (Wang 2014). Summary RR per 200 g/day for CVD = 0.92 (95% CI 0.90-0.95, I2 = 31%, n = 13); for coronary heart disease = 0.92 (95% CI 0.90-0.94, I2 = 0%, n = 15); for stroke = 0.84 (95% CI 0.76-0.92, I2 = 73%, n = 10) (Aune 2017). Highest versus lowest intake pooled RR for CVD = 0.83 (95% CI 0.79-0.86) (Zhan 2017).

Cancer incidence and mortality

Finding: Mixed evidenceCertainty: Limitedstudies disagree, or the effect depends on who is studied

Evidence basis: randomised trials

Observational syntheses report only weak inverse associations between fruit and vegetable intake and total cancer, while the large randomised trials that increased intake substantially were null.

Population: Adults in prospective cohorts, plus randomised trial populations including 3,088 women previously treated for early stage breast cancer, 2,079 adults with prior colorectal adenomas, and 161,808 postmenopausal women in the Women's Health Initiative.

Research details

Summary

Observational syntheses report only weak inverse associations between fruit and vegetable intake and total cancer, with summary relative risks close to the null, while large randomised trials that substantially increased fruit and vegetable intake showed no reduction in cancer incidence or cancer death. Pooled analyses for overall breast cancer found no association. The one significant result inside that pooled breast-cancer analysis was inverse and confined to oestrogen-receptor-negative tumours, where the highest versus lowest quintile of total vegetable intake gave RR 0.82 (95% CI 0.74-0.90), while the ER(+) estimate was null. The most defensible reading is that cohort associations are heavily confounded and that randomised evidence for cancer prevention has been largely null, with any benefit likely small or absent.

Why this certainty

Rated Limited because observational and randomised evidence point in different directions. Observational estimates are weak and heterogeneous, and the randomised trials that did intervene directly on fruit and vegetable intake were null for cancer endpoints. This discordance makes a causal protective effect for cancer prevention unsupported on current evidence.

Limitations

Observational associations are small and susceptible to confounding by screening behaviour, socioeconomic status and other lifestyle factors. Randomised dietary-change trials tested multifaceted dietary patterns rather than fruit and vegetables in isolation, achieved imperfect long-term adherence, and were underpowered for rarer cancers; the WHEL trial's 7.3-year follow-up may also be short relative to cancer latency.

Effect estimate

Summary RR per 200 g/day for total cancer = 0.97 (95% CI 0.95-0.99, I2 = 49%, n = 12) (Aune 2017). WHEL invasive breast cancer events: adjusted HR 0.96 (95% CI 0.80-1.14, P = .63); all-cause death: adjusted HR 0.91 (95% CI 0.72-1.15, P = .43). Pooled multivariable RR for ER(+) breast cancer, highest versus lowest quintile of total vegetable intake = 1.04 (95% CI 0.97-1.11); total fruit and vegetable intake was not associated with breast cancer overall (Jung 2013). Pooled multivariable RR for ER(-) breast cancer, highest versus lowest quintile of total vegetable intake = 0.82 (95% CI 0.74-0.90).

Sulforaphane metabolite recovery after cooked broccoli

Finding: Benefit supportedCertainty: Limitedstudies found a benefit from doing this

Evidence basis: randomised trials

Mustard powder increased a urinary sulforaphane metabolite in a small cooked-broccoli study.

Population: 12 healthy adults in an acute crossover food-preparation study.

Research details

Summary

In a randomized crossover study, 12 adults ate 200 g cooked broccoli with or without 1 g powdered brown mustard. Urinary sulforaphane N-acetyl-cysteine was higher with mustard. This measures availability of a metabolite, not prevention of cancer or any clinical disease.

Why this certainty

Limited for the preparation-specific biomarker effect. Clinical benefits remain unestablished and cannot be inherited from general fruit-and-vegetable cohorts.

Limitations

Single meals, a small sample and a urinary surrogate limit interpretation. Mustard preparations may differ in enzyme activity; no health benefit of a household recipe was tested.

What people say

Who discusses this?

Public statements, with positions specific to each source and topic. These views do not determine the scientific evidence assessment.

What the research shows ↑

Practical steps and precautions

How to try it

  1. Aim for fruit and vegetables across most meals rather than one large serving at a single point in the day, since the dose-response curves are built from total daily intake.
  2. Treat about five servings a day as an editorial starting point drawn from where the cohort curves flatten, not as a threshold established by trial evidence.
  3. Prefer whole fruit and vegetables over fruit juice and potatoes: in the largest cohort analysis, intakes of fruit juices and potatoes were not associated with total or cause-specific mortality.
  4. Broccoli preparation option: after cooking, add a small culinary amount of ground mustard if you enjoy it and it is suitable for you. A 12-person study used mustard powder to raise a urinary sulforaphane metabolite; no disease-prevention benefit was tested. Ordinary vegetables still matter without this extra step.

Precautions

  • The mortality and cardiovascular associations are observational, so this habit should be treated as risk reduction alongside usual medical care, not as a substitute for prescribed treatment.
  • Green leafy vegetables are a meaningful source of dietary vitamin K, which can interact with warfarin and similar anticoagulants; keep intake steady and tell your prescriber if you change it substantially.
  • A large increase in fruit and vegetable intake adds potassium and fibre, which may need clinical guidance if you have advanced kidney disease or a condition requiring a restricted diet.
  • Avoid mustard if you are allergic. A broccoli-preparation biomarker finding does not establish cancer prevention, and raw sprouts require particular food-safety care.

References

Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies

Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB · BMJ · 2014

Systematic review and dose-response meta-analysis of prospective cohort studiesVerified from abstract
Open original source

Fruit and Vegetable Intake and Mortality: Results From 2 Prospective Cohort Studies of US Men and Women and a Meta-Analysis of 26 Cohort Studies

Wang DD, Li Y, Bhupathiraju SN, Rosner BA, Sun Q, Giovannucci EL, Rimm EB, Manson JE, Willett WC, Stampfer MJ, Hu FB · Circulation · 2021

Two prospective cohort studies plus dose-response meta-analysis of 26 cohort studiesVerified from abstract
Open original source

Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies

Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S · International Journal of Epidemiology · 2017

Systematic review and dose-response meta-analysis of prospective studiesVerified from abstract
Open original source

Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies

Schwingshackl L, Schwedhelm C, Hoffmann G, Lampousi AM, Knuppel S, Iqbal K, Bechthold A, Schlesinger S, Boeing H · American Journal of Clinical Nutrition · 2017

Systematic review and dose-response meta-analysis of prospective studiesVerified from abstract
Open original source

Fruit and vegetable consumption and risk of cardiovascular disease: A meta-analysis of prospective cohort studies

Zhan J, Liu YJ, Cai LB, Xu FR, Xie T, He QQ · Critical Reviews in Food Science and Nutrition · 2017

Meta-analysis of prospective cohort studies with dose-response assessmentVerified from abstract
Open original source

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML · JAMA · 2007

Multi-institutional randomized controlled trial of dietary changeVerified from abstract
Open original source

Fruit and vegetable intake and risk of breast cancer by hormone receptor status

Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Scarmo S, Schairer C, Schouten LJ, Shikany JM, Sieri S, Tsugane S, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Zhang X, Ziegler RG, Smith-Warner SA · Journal of the National Cancer Institute · 2013

Pooled analysis of 20 prospective cohort studiesVerified from abstract
Open original source

Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group

Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J · New England Journal of Medicine · 2000

Randomized controlled trialVerified from abstract
Open original source

The Women's Health Initiative Randomized Trials and Clinical Practice: A Review

Manson JE, Crandall CJ, Rossouw JE, Chlebowski RT, Anderson GL, Stefanick ML, Aragaki AK, Cauley JA, Wells GL, LaCroix AZ, Thomson CA, Neuhouser ML, Van Horn L, Kooperberg C, Howard BV, Tinker LF, Wactawski-Wende J, Shumaker SA, Prentice RL · JAMA · 2024

Narrative review of the Women's Health Initiative randomized clinical trialsVerified from abstract
Open original source

Supplementation of the Diet by Exogenous Myrosinase via Mustard Seeds to Increase the Bioavailability of Sulforaphane in Healthy Human Subjects after the Consumption of Cooked Broccoli.

Okunade O, Niranjan K, Ghawi SK, Kuhnle G, Methven L. · Molecular nutrition & food research · 2018

Randomized crossover study of cooked broccoli with and without mustard powder in 12 healthy adultsVerified from abstract
Open original source

Community

Discussion

Have you tried this? What helped or made it difficult?

Reader experiences are separate from the scientific evidence. Explore all discussions

No discussions yet.

Be the first to ask a question or share your experience.

Sign in to vote or join the discussion.

Explore other habits in a shared category. Each has its own evidence and precautions.

Editorial history and review method

Revision 5 · Approved for publication · Codex (publication approval explicitly authorized by site owner; category migration)

Prepared and checked with AI. Publication approval does not imply independent expert review. Request a correction.

Applied the audit corrections for fruit-vegetable-intake. (1) Deleted the verdict sentence asserting that fruit and vegetable intake did not reduce cardiovascular events in randomised trials: no cited source reports a randomised fruit-and-vegetable trial with cardiovascular events as an outcome, and the sentence contradicted the entry's own limitations, which say no adequately powered trial has isolated the exposure for event prevention. (2) Deleted the uncited prostate-cancer clause from the verdict and the cancer summary; no source in the record reports any prostate-cancer analysis. (3) Added Jung 2013's own significant subgroup to the cancer summary and effect estimate: the ER(-) result (RR 0.82, 95% CI 0.74-0.90 for the highest versus lowest quintile of total vegetable intake), which the entry previously omitted while reporting only the ER(+) null. (4) Corrected the effectEstimate wording so the 1.04 estimate is labelled as the ER(+) estimate rather than described as overall breast cancer. (5) Completed two stored headline truncations that ended mid-word ('plateauing at ro…' and 'substantially increa…'). Second reviewer must re-check: (a) that no downstream copy turns the ER(-) subgroup into a general protective claim for breast cancer, since total fruit and vegetable intake was null overall; (b) that the cardiovascular-events outcome title still reads 'mortality and events' while every cited estimate is observational, which the audit noted but did not ask to change; (c) that the WHEL and Polyp Prevention Trial framing as multifaceted dietary-change trials rather than clean tests of produce is retained. October 3 video follow-up: Added cooked-broccoli/myrosinase guidance with the actual 12-person randomized food study, separate from vegetable-and-mortality associations. Verify biomarker framing and mustard suitability; do not convert fourfold recovery into a disease effect. Publication release 2026-10-04: site owner authorized a bounded AI audit and release of this exact revision. See docs/release-audit-2026-10-04.md for source-check findings and limits. No independent health-professional or peer review is claimed. Category migration 2026-10-04: removed the separate goals field; categories: Nutrition, Long-term health → Nutrition, Long-term health. Research assessments, sources, guidance, precautions, and evidence review dates are unchanged. This revision awaits publication approval; no new evidence review is claimed. Publication approval 2026-10-04: site owner explicitly accepted all current category-migration revisions for deployment and requested that remaining limitations be retained in docs/content-review-backlog.md. Approval applies to this exact content revision. No new evidence review, independent expert review, or clinical validation is claimed; existing precautions and disclosures remain in effect.